Carlos Javier Gutiérrez Cabrera

TL;DR: A simple disease-specific comorbidities index (COTE) helps assess mortality risk in patients with COPD and increases in the BODE and COTE were independently associated with increased risk of death.

TL;DR: A network-based analysis was applied to explore the associations between multiple comorbidities in chronic obstructive pulmonary disease patients and non-COPD controls and found there were more nodes and links in COPD compared with controls after adjusting for age, sex and number of subjects.

TL;DR: In patients with COPD, blood eosinophils ≥300 cells·μL–1 persisting over 2 years was not a risk factor for COPD exacerbations and high eOSinophil count was associated with better survival.

TL;DR: The CAT and the CCQ have similar ability for predicting all-cause mortality in patients with COPD, but were inferior to mMRC dyspnea scores, which are suggested to be useful for the new GOLD grading classification.

TL;DR: In this population of COPD patients, the BODE index had a better survival prediction than the ABCD GOLD categories and the COTE index was complimentary and significantly improved outcome prediction.